These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9687109)

  • 1. In-vitro activity of S-1090, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Tamaya T
    J Antimicrob Chemother; 1998 Jun; 41(6):664-5. PubMed ID: 9687109
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activities of E1101, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynecological patients.
    Mikamo H; Sato Y; Hayasaki Y; Kawazoe K; Tamaya T
    Chemotherapy; 1998; 44(5):328-30. PubMed ID: 9732148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of cefotaxime in the treatment of obstetric and gynaecological infections.
    Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical study of cefpimizole in obstetric and gynecologic infections.
    Sugiyama T; Miyahara K; Kato T
    Jpn J Antibiot; 1985 Apr; 38(4):1017-21. PubMed ID: 4032718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activities of telithromycin, a new ketolide, against bacteria causing infections in obstetric and gynaecological patients.
    Mikamo H; Hua YX; Sato Y; Hayasaki Y; Tamaya T
    J Antimicrob Chemother; 2000 Aug; 46(2):332-4. PubMed ID: 10933669
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin, in the fields of obstetrics and gynecology.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Tamaya T
    Chemotherapy; 1998; 44(3):153-6. PubMed ID: 9612604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on cefpiramide].
    Fukuda T
    Jpn J Antibiot; 1985 Sep; 38(9):2397-401. PubMed ID: 4079013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinidazole in the treatment of surgical and gynaecological infections.
    Giamarellou H; Gazis J; Vlachos G; Michalopoulos A; Aravantinos P; Daikos GK
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():129-36. PubMed ID: 7118769
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalosporins.
    Martens MG
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):291-304. PubMed ID: 2674797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonprophylactic role of cephalosporins in obstetrics and gynecology.
    LeFrock JL; Smith BR; Molavi A
    Bull N Y Acad Med; 1984 May; 60(4):416-25. PubMed ID: 6372917
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.
    Madinger NE; McGregor JA; McKinney PJ; Dembeck ST; Haskell CS; Johnson Z
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S349-52. PubMed ID: 8324145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetic, bacteriological and clinical studies on cefuzonam in the field of obstetrics and gynecology].
    Obata I; Tsuruoka N; Koike K; Morimoto O; Arihiro T; Hachiya S; Yamato T; Hayashi S; Hayashi M
    Jpn J Antibiot; 1987 May; 40(5):1047-65. PubMed ID: 3669284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous cefoxitin sodium for the treatment of infections in obstetric and gynaecological patients.
    Galask RP; Ohm M
    J Antimicrob Chemother; 1978 Jul; 4(B):241-3. PubMed ID: 690024
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ceftazidime: antibacterial activity and clinical efficacy in obstetrics and gynecology].
    Ninomiya K; Yoshimoto T; Hasegawa Y
    Jpn J Antibiot; 1984 Jan; 37(1):14-7. PubMed ID: 6374192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical chemotherapy with a new cephalosporin: cephalexin].
    Lamanna A; Gerli P; Periti P; Tomarchio C; Zucconi G
    Riv Ostet Ginecol; 1969 Dec; 24(12):399-411. PubMed ID: 5404220
    [No Abstract]   [Full Text] [Related]  

  • 16. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract]   [Full Text] [Related]  

  • 17. Limited-spectrum (first-generation) cephalosporins.
    Graham JM; Oshiro BT; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):449-59. PubMed ID: 1436923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Obata I; Hayashi F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1985 Apr; 38(4):940-53. PubMed ID: 4032731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Future of antibiotic therapy in various fields of medicine. 3. Gynecology and obstetric].
    Takase Z
    Nihon Rinsho; 1984 Mar; 42(3):587-97. PubMed ID: 6471452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental and clinical studies of ceftazidime in the field of obstetrics and gynecology].
    Obata I; Ryu F; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1983 Dec; 36(12):3491-506. PubMed ID: 6371297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.